Chronic phencyclidine increases methionine-enkephalin level in mouse striatum

Area of Science:

• Neuroscience
• Pharmacology

Background:

• Phencyclidine-HCl (PCP-HCl) is a dissociative drug with known neurological effects.
• Methionine-enkephalin is an endogenous opioid peptide involved in various brain functions.

Purpose of the Study:

• To investigate the impact of chronic phencyclidine-HCl administration on methionine-enkephalin levels in different brain regions.
• To determine if PCP alters enkephalinergic neuronal activity.

Main Methods:

• Rats were administered phencyclidine-HCl (10 mg/kg) for 6-7 days (chronic) or acutely.
• Methionine-enkephalin levels were measured in the striatum, medulla oblongata/pons, midbrain, hypothalamus, and cortex.

Main Results:

• Chronic PCP-HCl administration significantly increased methionine-enkephalin levels in the striatum.
• Acute PCP-HCl administration did not alter striatal methionine-enkephalin levels.
• Methionine-enkephalin levels remained unchanged in other brain regions after chronic PCP treatment.

Conclusions:

• Chronic phencyclidine-HCl administration selectively alters enkephalinergic neuronal activity in the striatum.
• The findings suggest a specific neurochemical adaptation in the striatum in response to prolonged PCP exposure.